Research Funding

  • May 4, 2015 - April 30, 2021 - Improving risk allocation and developing novel therapies for children with T-ALL , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA193776
  • June 1, 2010 - May 31, 2015 - Interplay of Innate and Adaptive Immunity in Lupus Pathogenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01AI089831
  • July 11, 2003 - June 30, 2007 - Role of CD45 in Hematopoiesis and Lymphomagenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08CA098418

Education

University of Iowa, B.S August, 1988, Physiology
Washington University School of Medicine, Ph.D., May, 1997, Developmental Biology
Washington University School of Medicine, M.D., May, 1997, Medicine
University of California, San Francisco, Resident, 1997-99, Pediatrics
University of California, San Francisco, Fellow, 1999-03, Hematology/Oncology
University of California, San Francisco, Post-Doctoral Fellow, 2001-2007, Immunology

Honors & Awards

  • 1987
    Mortar Board Honor Society, University of Iowa
  • 1988
    Honors Graduate, University of Iowa
  • 1988
    University of Iowa Homecoming Award for Excellence in Scholarship, Leadership, and Service
  • 1990
    Medical Scientist Training Program Fellowship, Washington University
  • 1990
    Edmond V. Cowdry Prize in Histology, Washington University
  • 1993
    Spencer T. and Ann W. Olin Foundation Medical Scientist Fellowship, Washington University
  • 1995
    Barbara Jackshik Award for Excellence in the Field of Cellular Regulation, Washington University
  • 1996
    American College of Physicians Award for Excellence in Physical Diagnosis
  • 1997
    American Medical Women's Association Janet M. Glasgow Memorial Achievement Citation, presented to women graduating in the top ten percent of their medical school class
  • 1997
    Missouri State Medical Association Award for Outstanding Achievement in Medicine
  • 1997
    Alpha Omega Alpha, Washington University School of Medicine
  • 1997
    UCSF Molecular Medicine Research Fellowship Program
  • 2001
    Molecular Oncology Investigator, University of California San Francisco Cancer Center
  • 2004
    FASEB Summer Protein Phosphatase Research Conference Poster Award
  • 2005
    Nominee, Department of Pediatrics Housestaff Teaching Award, UCSF
  • 2007-10
    Nominee, Fellow Mentoring Award, Department of Pediatrics, UCSF
  • 2008
    St. Baldrick's Foundation, Young Investigator Career Development Award
  • 2009
    Alex Lemonade Stand Young Investigator Career Development Award
  • 2010
    Histiocyte Society Nezelof Prize in Basic Science

Selected Publications

  1. Meyer LK, Huang I, Huang BJ, Chung JH, Pawar A, Hermiston ML, Loh ML, Ohgami RS, Ruiz-Cordero R, Bhargava P, Marinoff AE. Hemophagocytic lymphohistiocytosis and clonally related T-cell malignancies in a pediatric patient. Pediatr Blood Cancer. 2023 Dec; 70(12):e30677.  View on PubMed
  2. Nader Kim El-Mallawany, Lisa Giulino-Roth, John M. Burke, Michelle Hermiston, Carl E. Allen. Mature B-cell lymphomas in adolescents and young adults. eJHaem. 2023 Sep 1.  View on PubMed
  3. El-Mallawany NK, Alexander S, Fluchel M, Hayashi RJ, Lowe EJ, Giulino-Roth L, Wistinghausen B, Hermiston M, Allen CE, COG NHL Committee. Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30565.  View on PubMed
  4. Fries C, Hermiston ML. Challenging T-ALL to IL-7Rp dual inhibition. Blood. 2023 Jul 13; 142(2):124-126.  View on PubMed
  5. Keenan BP, Sibley A, Zhang L, Westring AF, Velazquez AI, Bank EM, Bergsland EK, Boreta L, Conroy P, Daras M, Hermiston M, Hsu G, Paris PL, Piawah S, Sinha S, Sosa JA, Tsang M, Venook AP, Wong M, Yom SS, Van Loon K. Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center. Oncologist. 2023 Jul 13.  View on PubMed
  6. McNerney KO, Si Lim SJ, Ishikawa K, Dreyzin A, Vatsayan A, Chen JJ, Baggott C, Prabhu S, Pacenta HL, Philips C, Rossoff J, Stefanski HE, Talano JA, Moskop A, Verneris M, Myers D, Karras NA, Brown P, Bonifant CL, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Baumeister SHC, Fabrizio VA, Chinnabhandar V, Egeler E, Mavroukakis S, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL. Blood Adv. 2023 Jun 27; 7(12):2758-2771.  View on PubMed
  7. Si Lim SJ, Ford JB, Hermiston ML. How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults. Blood. 2023 Jun 22; 141(25):3019-3030.  View on PubMed
  8. Devine KJ, Fries C, Hermiston M, Wistinghausen B. How I approach B-lymphoblastic lymphoma in children. Pediatr Blood Cancer. 2023 Aug; 70(8):e30401.  View on PubMed
  9. Wayne AS, Huynh V, Hijiya N, Rouce RH, Brown PA, Krueger J, Kitko CL, Ziga ED, Hermiston ML, Richards MK, Baruchel A, Schuberth PC, Rossi J, Zhou L, Goyal L, Jain R, Vezan R, Masouleh BK, Lee DW. Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica. 2023 03 01; 108(3):747-760.  View on PubMed
  10. Stefanski HE, Eaton A, Baggott C, Rossoff J, Verneris MR, Prabhu S, Pacenta HL, Phillips CL, Talano JA, Moskop A, Margossian SP, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski MC, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium. Blood Adv. 2023 02 28; 7(4):541-548.  View on PubMed
  11. Temple WC, Mueller S, Hermiston ML, Burkhardt B. Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults. Best Pract Res Clin Haematol. 2023 03; 36(1):101449.  View on PubMed
  12. Root MC, Koo J, Collins G, Penumarthy NL, Hermiston M, Bogetz JF. Allowing Relationships to Unfold: Consult Reason and Topics Discussed in Initial and Subsequent Palliative Care Visits Among Children Who Died From Relapsed/Refractory Cancer. J Pediatr Hematol Oncol Nurs. 2023 May-Jun; 40(3):170-177.  View on PubMed
  13. Sewell JL, Joshi M, Thanh C, Apollon C, Austin E, Burke C, Cornes S, Davis JA, Hermiston M. Pre-clerkship Teaching and Learning in the Virtual Learning Environment: Lessons Learned and Future Directions. Med Sci Educ. 2022 Nov 19; 1-5.  View on PubMed
  14. L. Meyer, Ritu P. Roy, B. Huang, S. Kimura, Petri Polonen, C. Delgado-Martin, T. Vincent, T. Ryan, B. Wood, Y. Liu, J. Zhang, C. Mullighan, T. Horton, M. Loh, M. Devidas, E. Raetz, R. Hayashi, S. Winter, K. Dunsmore, S. Hunger, D. Teachey, M. Hermiston, Adam B. Olshen. 049 A TARGETED GENE EXPRESSION CLASSIFIER IDENTIFIES PEDIATRIC T-ALL PATIENTS AT HIGH RISK FOR END INDUCTION MINIMAL RESIDUAL DISEASE POSITIVITY. Leukemia Research. 2022 Oct 1; 121:s34-s35.  View on PubMed
  15. Schultz LM, Eaton A, Baggott C, Rossoff J, Prabhu S, Keating AK, Krupski C, Pacenta H, Philips CL, Talano JA, Moskop A, Baumeister SHC, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Kunicki M, Mavroukakis S, Egeler E, Li Y, Mackall CL, Curran KJ, Verneris MR, Laetsch TW, Stefanski H. Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia. J Clin Oncol. 2023 01 10; 41(2):354-363.  View on PubMed
  16. Moskop A, Pommert L, Baggott C, Prabhu S, Pacenta HL, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston ML, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Guest EM, Breese EH, Schultz LM. Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia. Blood Adv. 2022 07 26; 6(14):4251-4255.  View on PubMed
  17. Griffin Collins, Hannah Beaman, Alvin Ho, Michelle Hermiston, Harvey Cohen, Elizabeth Dzeng. Anatomy of a Consult: How a Multidisciplinary Pediatric Stem Cell Transplant Team Considers Specialty Palliative Care Consultation (GP722). Journal of Pain and Symptom Management. 2022 Jun 1; 63(6):1123-1124.  View on PubMed
  18. Goyal G, Tazi A, Go RS, Rech KL, Picarsic JL, Vassallo R, Young JR, Cox CW, Van Laar J, Hermiston ML, Cao XX, Makras P, Kaltsas G, Haroche J, Collin M, McClain KL, Diamond EL, Girschikofsky M. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood. 2022 04 28; 139(17):2601-2621.  View on PubMed
  19. Meyer LK, Delgado-Martin C, Sharp PP, Huang BJ, McMinn D, Vincent TL, Ryan T, Horton TM, Wood BL, Teachey DT, Taunton J, Kirk CJ, Hermiston ML. Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia. Br J Haematol. 2022 07; 198(1):137-141.  View on PubMed
  20. Fabrizio VA, Boelens JJ, Mauguen A, Baggott C, Prabhu S, Egeler E, Mavroukakis S, Pacenta H, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Chinnabhandar V, Kunicki M, Goksenin AY, Mackall CL, Laetsch TW, Schultz LM, Curran KJ. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022 04 12; 6(7):1961-1968.  View on PubMed

Go to UCSF Profiles, powered by CTSI